These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2349607)

  • 21. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
    Moore KT; Byra W; Vaidyanathan S; Natarajan J; Ariyawansa J; Salih H; Turner KC
    Br J Clin Pharmacol; 2015 Jun; 79(6):907-17. PubMed ID: 25475601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Chu Y; Zhang L; Wang XY; Guo JH; Guo ZX; Ma XH
    J Ethnopharmacol; 2011 Oct; 137(3):1457-61. PubMed ID: 21878380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prothrombin fragment F 1 + 2 and oral anticoagulant therapy.
    Li Z; Wu J; Mammen EF
    Thromb Res; 1994 Sep; 75(6):601-7. PubMed ID: 7831679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers.
    Faaij RA; van Griensven JM; Schoemaker RC; Goggin T; Guenzi A; Kroon JM; Burggraaf J; Cohen AF
    Eur J Clin Pharmacol; 2001 Apr; 57(1):25-9. PubMed ID: 11372586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin.
    Nagashima R; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1969; 10(1):22-35. PubMed ID: 5765183
    [No Abstract]   [Full Text] [Related]  

  • 26. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Zhu M; Chan KW; Ng LS; Chang Q; Chang S; Li RC
    J Pharm Pharmacol; 1999 Feb; 51(2):175-80. PubMed ID: 10217316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
    Zhou L; Wang S; Zhang Z; Lau BS; Fung KP; Leung PC; Zuo Z
    J Ethnopharmacol; 2012 Sep; 143(2):648-55. PubMed ID: 22867637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
    Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
    Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of interaction between famotidine and warfarin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; Buntinx A; Distlerath L; De Schepper PJ
    Int J Clin Pharmacol Res; 1990; 10(3):167-71. PubMed ID: 2228341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
    Hitzenberger G; Sommer W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin.
    Yan JH; Meyers D; Lee Z; Danis K; Neelakantham S; Majumdar T; Rebello S; Sunkara G; Chen J
    J Clin Pharmacol; 2014 Jul; 54(7):800-8. PubMed ID: 24619917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats.
    Lo AC; Chan K; Yeung JH; Woo KS
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):257-62. PubMed ID: 1301354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
    Niopas I; Toon S; Aarons L; Rowland M
    Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Hovhannisyan AS; Abrahamyan H; Gabrielyan ES; Panossian AG
    Phytomedicine; 2006 May; 13(5):318-23. PubMed ID: 16635739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarin.
    Ermer JC; Hicks DR; Wheeler SC; Kraml M; Jusko WJ
    Clin Pharmacol Ther; 1994 Mar; 55(3):305-16. PubMed ID: 8143396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766.
    Oberwittler H; Hirschfeld-Warneken A; Wesch R; Willerich H; Teichert L; Lehr KH; Ding R; Haefeli WE; Mikus G
    J Clin Pharmacol; 2007 Jan; 47(1):70-7. PubMed ID: 17192504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.
    Weiss D; Knight R; Zhou S; Palmisano M; Chen N
    Clin Drug Investig; 2015 Jul; 35(7):455-61. PubMed ID: 26024727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
    Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
    Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin.
    Toon S; Holt BL; Mullins FG; Bullingham R; Aarons L; Rowland M
    Br J Clin Pharmacol; 1990 Nov; 30(5):743-50. PubMed ID: 2271374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.